⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1751665 | 0.75 | — | — | |
| SCHEMBL3310419 | 0.73 | CA2 (0.41) | — | |
| SCHEMBL10025586 | 0.73 | — | — | |
| SCHEMBL208791 | 0.71 | — | — | |
| SCHEMBL177789 | 0.71 | — | — | |
| Ethylene SCHEMBL27432797 | 0.71 | DHFR (0.34) | — | |
| SCHEMBL724276 | 0.69 | — | — | |
| SCHEMBL3284719 | 0.69 | — | — | |
| SCHEMBL4266233 | 0.69 | — | — | |
| SCHEMBL1618240 | 0.69 | CA2 (0.48) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 128 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0480659-B1 | Use of Angiotensin-II antagonists for the manufacture of a medicament for the treatment of hyperuricemia | MERCK & CO INC (US) | 1996-09-04 | — | — | EP | claimed |
| CN-104245681-B | (1,2, 3-Azole) sulfonyl derivatives | 南京优迪生物医药有限公司 | 2017-09-26 | — | — | CN | disclosed |
| EP-2751084-B1 | PYRIMIDINE CARBOXAMIDE DERIVATIVES | EUDIS BIOTECH LLC (CN) | 2016-09-21 | — | — | EP | disclosed |
| US-9249107-B2 | Pyrimidine carboxamide derivatives | MAEHR HUBERT (US) | 2016-02-02 | — | — | US | disclosed |
| US-20150087665-A1 | Pyrimidine carboxamide derivatives | Maehr, Hubert (US) | 2015-03-26 | — | — | US | disclosed |
| EP-2834223-A2 | (1,2,3-TRIAZOLYL) SULFONYL DERIVATIVES | Apac Pharmaceutical LLC. (US) | 2015-02-11 | — | — | EP | disclosed |
| US-8853248-B2 | (1,2,3-triazolyl)sulfonyl derivatives | MAEHR HUBERT (US) | 2014-10-07 | — | — | US | disclosed |
| EP-2751084-A1 | PYRIMIDINE CARBOXAMIDE DERIVATIVES | Apac Pharmaceutical LLC. (US) | 2014-07-09 | — | — | EP | disclosed |
| US-8580805-B2 | Pyrimidine carboxamide derivatives | MAEHR HUBERT (US) | 2013-11-12 | — | — | US | disclosed |
| WO-2013151597-A2 | (1,2,3-TRIAZOLYL) SULFONYL DERIVATIVES | APAC PHARMACEUTICAL LLC. (US) | 2013-10-10 | — | — | WO | disclosed |
| EP-1067430-A1 | Silver halide photographic emulsion and photographic light-sensitive material using the same | FUJI PHOTO FILM CO., LTD. (JP) | 2001-01-10 | — | — | EP | disclosed |
| EP-1061411-A1 | Silver halide photographic emulsion and photographic light-sensitive material using the same | FUJI PHOTO FILM CO., LTD. (JP) | 2000-12-20 | — | — | EP | disclosed |
| US-6117629-A | SILVER HALIDE GRAINS HAVING A LIGHT ABSORPTION STRENGTH OF 100 OR MORE PER UNIT SURFACE AREA, WHEREIN THE SILVER HALIDE GRAINS HAVE BEEN SPECTRALLY SENSITIZED WITH A SENSITIZING DYE THAT IS MULTILAYER ADSORBED ONTO A SURFACE OF THE GRAINS | FUJI PHOTO FILM CO., LTD. (JP) | 2000-09-12 | — | — | US | disclosed |
| US-5928854-A | QUATERNIZED METHINE DYE; HIGH LIGHT ABSORPTION; COLOR PHOTOGRAPHY | FUJI PHOTO FILM CO., LTD. (JP) | 1999-07-27 | — | — | US | disclosed |
| EP-0905558-A1 | Photographic silver halide emulsion | KONICA CORPORATION (JP) | 1999-03-31 | — | — | EP | disclosed |
| US-5885764-A | SPECTRAL SENSITIVITY | FUJI PHOTO FILM CO., LTD. (JP) | 1999-03-23 | — | — | US | disclosed |
| EP-0838719-A2 | Silver halide photographic emulsion and silver halide photographic material containing said silver halide photographic emulsion | FUJI PHOTO FILM CO., LTD. (JP) | 1998-04-29 | — | — | EP | disclosed |
| EP-0480659-B1 | Use of Angiotensin-II antagonists for the manufacture of a medicament for the treatment of hyperuricemia | MERCK & CO INC (US) | 1996-09-04 | — | — | EP | disclosed |
| US-5260322-A | Angiotension II antagonists in the treatment of hyperuricemia | MERCK & CO., INC. (US) | 1993-11-09 | — | — | US | disclosed |
| EP-0480659-A2 | Use of Angiotensin-II antagonists for the manufacture of a medicament for the treatment of hyperuricemia | MERCK & CO. INC. (US) | 1992-04-15 | — | — | EP | disclosed |